Tuning tumor-specific T-cell activation: a matter of costimulation?
about
The immunogenicity of colorectal cancers with high-degree microsatellite instabilityMolecular Insights into γδ T Cell Costimulation by an Anti-JAML AntibodyTemporal transcriptome changes induced by MDV in Marek's disease-resistant and -susceptible inbred chickens.B7-H1 pathway and its role in the evasion of tumor immunity.Chemokines, costimulatory molecules and fusion proteins for the immunotherapy of solid tumors.Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma.Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors.Enhanced sensitivity to IL-2 signaling regulates the clinical responsiveness of IL-12-primed CD8(+) T cells in a melanoma modelMismatch repair gene defects in sporadic colorectal cancer enhance immune surveillance.Targeting costimulatory pathways for tumor immunotherapy.Engineering antigen-specific primary human NK cells against HER-2 positive carcinomasOX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal.T cell optimization for the treatment of pancreatic cancer.Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone.A GMP-compliant protocol to expand and transfect cancer patient T cells with mRNA encoding a tumor-specific chimeric antigen receptor.Costimulation by chimeric antigen receptors revisited the T cell antitumor response benefits from combined CD28-OX40 signalling.Engineered T cells for the adoptive therapy of B-cell chronic lymphocytic leukaemia.Induction of an antitumour adaptive immune response elicited by tumour cells expressing de novo B7-1 mainly depends on the anatomical site of their delivery: the dose applied regulates the expansion of the response.Stable expression of chimeric anti-CD3 receptors on mammalian cells for stimulation of antitumor immunity.Colon cancer and the immune system: the role of tumor invading T cells.Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity.Electroporation of mRNA as Universal Technology Platform to Transfect a Variety of Primary Cells with Antigens and Functional Proteins.Immunoglobulin g from breast cancer patients regulates MCF-7 cells migration and MMP-9 activity by stimulating muscarinic acetylcholine receptorsIdentification of a circulating soluble form of CD80: levels in patients with hematological malignancies
P2860
Q24814928-54737BE5-EBD6-419C-810B-FCE9A21F0557Q27666534-0448B822-5C20-47EE-9B46-3181C9049349Q31033273-752CE79E-3C85-43A1-8546-2EDDC0D3AAA3Q35117398-559C803C-7D2F-4216-BC6E-B32971C37F61Q35580479-C3167FC6-704C-4CCD-BE42-773767015E94Q36004284-8AA5C3B2-C8A5-4CE2-BE1B-99131B5B8554Q36219738-775AFA1D-0765-4C1C-A19A-8D6D8816D5C3Q36494531-E7CA62C8-2BC0-4D92-9487-9C7CB2504667Q36685431-08E45E16-1005-4498-9508-EFBC85D58FD2Q36844950-E32F1482-41C4-4A4B-8589-E18FF116B746Q36970863-B040ACA4-7F4F-42D9-AF89-AA0C12FA6099Q38374889-143C4450-8BA0-45F0-9285-9EA7C34E9E9DQ38638035-96AE3DFB-10E7-4C45-AF17-F0F749746EC8Q38823747-F81C4C7D-4020-4BA0-B12D-2BF608E5B6FDQ38983814-46946720-FAFB-4A7E-80DD-758BAB35631CQ39452134-7F585C0D-B011-4D60-8040-449B4391FE37Q39718346-39546767-2815-4756-B612-C158476148E5Q40614567-12C99250-8298-48AA-AFA9-102D7721FDC6Q40632755-2153B50E-F5FD-4A70-876C-E212C68431A0Q42725940-322EE751-984A-43A9-B701-6A56226EC7B5Q45857417-34B4314E-32E2-4973-90AC-561ABA931CDEQ50035982-9170DF79-6DD8-4CF6-AF0C-2BFCB7D731FCQ56773128-77D3EC8E-4DBA-4A89-9CA8-30A1A6132022Q56903301-B812B849-F819-46B6-A8C2-157A73340B14
P2860
Tuning tumor-specific T-cell activation: a matter of costimulation?
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Tuning tumor-specific T-cell activation: a matter of costimulation?
@ast
Tuning tumor-specific T-cell activation: a matter of costimulation?
@en
Tuning tumor-specific T-cell activation: a matter of costimulation?
@nl
type
label
Tuning tumor-specific T-cell activation: a matter of costimulation?
@ast
Tuning tumor-specific T-cell activation: a matter of costimulation?
@en
Tuning tumor-specific T-cell activation: a matter of costimulation?
@nl
prefLabel
Tuning tumor-specific T-cell activation: a matter of costimulation?
@ast
Tuning tumor-specific T-cell activation: a matter of costimulation?
@en
Tuning tumor-specific T-cell activation: a matter of costimulation?
@nl
P2093
P1433
P1476
Tuning tumor-specific T-cell activation: a matter of costimulation?
@en
P2093
Andreas Hombach
Barbara Seliger
Claudia Heuser
Hinrich Abken
Kai Kronfeld
P304
P356
10.1016/S1471-4906(02)02180-4
P577
2002-05-01T00:00:00Z